The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy
Journal of Nihon University Medical Association
doi 10.4264/numa.77.5_333
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
The Nihon University Medical Association